Chung‐Ping Hsu

2.0k total citations
67 papers, 1.6k citations indexed

About

Chung‐Ping Hsu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Chung‐Ping Hsu has authored 67 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 28 papers in Molecular Biology and 24 papers in Surgery. Recurrent topics in Chung‐Ping Hsu's work include Esophageal Cancer Research and Treatment (12 papers), Esophageal and GI Pathology (11 papers) and Lung Cancer Diagnosis and Treatment (9 papers). Chung‐Ping Hsu is often cited by papers focused on Esophageal Cancer Research and Treatment (12 papers), Esophageal and GI Pathology (11 papers) and Lung Cancer Diagnosis and Treatment (9 papers). Chung‐Ping Hsu collaborates with scholars based in Taiwan, United States and Indonesia. Chung‐Ping Hsu's co-authors include Jiunn‐Liang Ko, Tzu‐Pin Lu, Mong‐Hsun Tsai, Eric Y. Chuang, Liang‐Chuan Lai, Jang‐Ming Lee, Li‐Wen Lee, Chuhsing Kate Hsiao, Pei‐Chun Chen and Pan‐Chyr Yang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer.

In The Last Decade

Chung‐Ping Hsu

65 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chung‐Ping Hsu Taiwan 23 877 415 292 269 237 67 1.6k
Ken‐ichi Kozaki Japan 21 906 1.0× 178 0.4× 357 1.2× 312 1.2× 118 0.5× 34 1.5k
Sang‐Hyun Song South Korea 26 938 1.1× 177 0.4× 187 0.6× 382 1.4× 330 1.4× 79 1.7k
Hongcheng Zhu China 27 929 1.1× 431 1.0× 586 2.0× 527 2.0× 333 1.4× 97 1.9k
Hao Wen China 26 981 1.1× 274 0.7× 517 1.8× 453 1.7× 279 1.2× 103 2.1k
Hongzhen Li United States 20 712 0.8× 394 0.9× 267 0.9× 639 2.4× 159 0.7× 61 1.6k
Liudmila L. Kodach Netherlands 22 1.0k 1.2× 235 0.6× 467 1.6× 633 2.4× 376 1.6× 53 1.9k
Miki Shitashige Japan 26 1.1k 1.3× 215 0.5× 299 1.0× 435 1.6× 103 0.4× 43 1.9k
Xiao Tan China 20 975 1.1× 315 0.8× 440 1.5× 222 0.8× 85 0.4× 53 1.4k
Vivi Kasim China 24 1.3k 1.5× 205 0.5× 528 1.8× 253 0.9× 161 0.7× 62 1.9k

Countries citing papers authored by Chung‐Ping Hsu

Since Specialization
Citations

This map shows the geographic impact of Chung‐Ping Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chung‐Ping Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chung‐Ping Hsu more than expected).

Fields of papers citing papers by Chung‐Ping Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chung‐Ping Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chung‐Ping Hsu. The network helps show where Chung‐Ping Hsu may publish in the future.

Co-authorship network of co-authors of Chung‐Ping Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Chung‐Ping Hsu. A scholar is included among the top collaborators of Chung‐Ping Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chung‐Ping Hsu. Chung‐Ping Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chiang, Nai‐Jung, Chung‐Ping Hsu, Jin‐Shing Chen, et al.. (2024). MO50-3 TCOG T3221 study: the registry of genetic alterations of Taiwan biliary tract cancer. Annals of Oncology. 35. S1355–S1355. 1 indexed citations
2.
Lin, Chih‐Hung, Tzu‐Hung Hsiao, Bharath Kumar Velmurugan, et al.. (2022). AGR2 expression as a predictive biomarker for therapy response in esophageal squamous cell carcinoma. PLoS ONE. 17(11). e0276990–e0276990. 6 indexed citations
3.
Chuang, Huai‐Chia, Chiao‐Fang Teng, Ming-Ching Lee, et al.. (2019). MAP4K3/GLK Promotes Lung Cancer Metastasis by Phosphorylating and Activating IQGAP1. Cancer Research. 79(19). 4978–4993. 39 indexed citations
4.
Lee, Ming-Ching, et al.. (2019). Molecular profiling of thymoma with myasthenia gravis: Risk factors of developing myasthenia gravis in thymoma patients. Lung Cancer. 139. 157–164. 8 indexed citations
5.
Shen, Chengying, Li‐Han Chen, Wen‐Chun Lin, et al.. (2018). The extracellular SEMA domain attenuates intracellular apoptotic signaling of semaphorin 6A in lung cancer cells. Oncogenesis. 7(12). 95–95. 18 indexed citations
6.
Lin, Jingwei, et al.. (2017). The impact of pathological complete response after neoadjuvant chemoradiotherapy in locally advanced squamous cell carcinoma of esophagus. Journal of the Chinese Medical Association. 81(1). 18–24. 23 indexed citations
7.
Lin, Chih‐Hung, et al.. (2014). The relationship between Helicobacter pylori and cancer risk. European Journal of Internal Medicine. 25(3). 235–240. 33 indexed citations
8.
Tang, Sheau‐Chung, et al.. (2013). Glutathione S -Transferase Mu2 Suppresses Cancer Cell Metastasis in Non–Small Cell Lung Cancer. Molecular Cancer Research. 11(5). 518–529. 16 indexed citations
9.
Hsu, Po‐Kuei, Hsuan‐Yu Chen, Yi‐Chen Yeh, et al.. (2013). TPX2 expression is associated with cell proliferation and patient outcome in esophageal squamous cell carcinoma. Journal of Gastroenterology. 49(8). 1231–1240. 46 indexed citations
10.
Hsu, Chung‐Ping, et al.. (2012). A retrospective study of postoperative chemoradiotherapy for locally advanced esophageal squamous cell carcinoma. Formosan Journal of Surgery. 45(6). 172–177. 6 indexed citations
11.
Lu, Tzu‐Pin, Liang‐Chuan Lai, Mong‐Hsun Tsai, et al.. (2011). Integrated Analyses of Copy Number Variations and Gene Expression in Lung Adenocarcinoma. PLoS ONE. 6(9). e24829–e24829. 58 indexed citations
12.
Wu, You‐Lin, et al.. (2011). Electrical characterization of single cells using polysilicon wire ion sensor in an isolation window. Biomedical Microdevices. 13(5). 939–947. 2 indexed citations
13.
Tang, Sheau‐Chung, Ming‐Fang Wu, Ruey‐Hong Wong, et al.. (2011). Epigenetic mechanisms for silencing glutathione S‐transferase m2 expression by hypermethylated specificity protein 1 binding in lung cancer. Cancer. 117(14). 3209–3221. 28 indexed citations
14.
Lu, Tzu‐Pin, Mong‐Hsun Tsai, Jang‐Ming Lee, et al.. (2010). Identification of a Novel Biomarker, SEMA5A , for Non–Small Cell Lung Carcinoma in Nonsmoking Women. Cancer Epidemiology Biomarkers & Prevention. 19(10). 2590–2597. 239 indexed citations
15.
Hsu, Po‐Kuei, Sen‐Ei Shai, John Wang, & Chung‐Ping Hsu. (2010). Esophageal Metastasis From Occult Lung Cancer. Journal of the Chinese Medical Association. 73(6). 327–330. 4 indexed citations
16.
Hsu, Chung‐Ping, et al.. (2008). Clinical Outcome of Postoperative Intensity-Modulated Radiotherapy for Esophageal Cancer. 15(4). 269–278. 3 indexed citations
17.
Hsiao, Yi‐Min, et al.. (2008). Induction of premature senescence in human lung cancer by fungal immunomodulatory protein from Ganoderma tsugae. Food and Chemical Toxicology. 46(5). 1851–1859. 53 indexed citations
18.
19.
Hsu, Chung‐Ping, et al.. (2002). Experiences in the Treatment of Recurrent Pneumothorax after VATS: Focusing on Operative Findings. 17(3). 226–231. 1 indexed citations
20.
Chiang, Chi‐Der, et al.. (2001). Primary Pulmonary Meningioma. 16(4). 244–249. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026